Biomarker identification using dynamic time warping analysis: a longitudinal cohort study of patients with COVID-19 in a UK tertiary hospital

• Alastair Watson,
• Hang Phan,
• Florina Borca,
• Sarah Williams,
• Tom Wilkinson,
• Hannah Burke,
• Anna Freeman,
• Ahilanandan Dushianthan,
• Michael Celinski,
• James Batchelor,
• Natasha Sheard,
• Paul Fitzpatrick,
• Dónal Landers,
• André Freitas,
• Paul O’Regan,
• Oskar Wysocki

Affiliations

Alastair Watson

Faculty of Medicine, University of Southampton, Southampton, UK

Hang Phan

Clinical Informatics Research Unit, University of Southampton Faculty of Medicine, Southampton, UK

Florina Borca

Institute for Life Sciences, University of Southampton, Southampton, UK

Sarah Williams

University Hospital Southampton NHS Foundation Trust, Southampton, UK

Tom Wilkinson

Faculty of Medicine, University of Southampton, Southampton, UK

Hannah Burke

Faculty of Medicine, University of Southampton, Southampton, UK

Anna Freeman

Faculty of Medicine, University of Southampton, Southampton, UK

Ahilanandan Dushianthan

Faculty of Medicine, University of Southampton, Southampton, UK

Michael Celinski

Faculty of Medicine, University of Southampton, Southampton, UK

James Batchelor

Faculty of Medicine, University of Southampton, Southampton, UK

Natasha Sheard

University Hospital Southampton NHS Foundation Trust, Southampton, UK

Paul Fitzpatrick

University of Manchester, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, Manchester, UK

Dónal Landers

Digital Experimental Cancer Medicine Team, University of Manchester, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, Alderley Edge, Cheshire, UK

André Freitas

Digital Experimental Cancer Medicine Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK

Paul O’Regan

Digital Experimental Cancer Medicine Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK

Oskar Wysocki

Digital Experimental Cancer Medicine Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK